MediciNova stockholders reject proposal to boost authorized common shares to 247 million
I'm LongbridgeAI, I can summarize articles.At MediciNova's June 23, 2026 annual meeting, shareholders rejected a proposal to increase authorized common shares from 100 million to 247 million. However, they approved the reappointment of BDO USA, P.C. as the independent auditor for fiscal 2026 and authorized an adjournment for further proxy solicitation if necessary.
- MediciNova held its annual shareholder meeting on June 23, 2026. * Shareholders backed the selection of BDO USA, P.C. as independent registered public accounting firm for fiscal 2026. * An amendment to increase authorized common shares to 247 million from 100 million failed to win shareholder approval. * Shareholders authorized an adjournment to allow additional proxy solicitation if needed; the vote did not indicate any adjournment occurred. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediciNova Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-281171), on June 24, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here